DBV Technologies SA (DBVT)
21.90
+0.64
(+3.03%)
USD |
NASDAQ |
Feb 09, 10:40
DBV Technologies Shareholders Equity (Quarterly) : 52.85M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| EDAP TMS SA | 27.40M |
| Cellectis SA | 100.48M |
| Ascendis Pharma A/S | -204.54M |
| Akari Therapeutics Plc | 22.69M |
| Biodexa Pharmaceuticals Plc | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 110.50M |
| Total Liabilities (Quarterly) | 57.64M |
| Debt to Equity Ratio | 0.3027 |
| Current Ratio | 1.796 |
| Net Debt Paydown Yield | -0.21% |